Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease

201153 citationsJournal Article

Authors

Björn Wíkström · Uppsala University Hospital

Sunil Bhandari · Hull and East Yorkshire Hospitals NHS Trust

Peter Bárány · Karolinska Institutet

Philip A. Kalra

Søren Ladefoged · Copenhagen University Hospital

Jan Wilske · Värnamo Sjukhus

Lars L. Thomsen · Pharmacosmos (Denmark)

Abstract

Iron isomaltoside 1000 was clinically well tolerated, safe and effective. This new intravenous iron may offer a further valuable choice in treating the anemia of CKD.

Topics & Keywords

Iron Metabolism and Disorders Erythropoietin and Anemia Treatment Hemoglobinopathies and Related Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Nephrology

Volume 24, Issue 5, pp. 589-596

DOI: 10.5301/jn.2011.6248

Field-Weighted Citation Impact: 3.12